ONKURE THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ONKURE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $6.00K.
- ONKURE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $10.00K.
- ONKURE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $10.00K.
- ONKURE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $6.00K, a 95.68% decline year-over-year.
- ONKURE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $26.00K.
- ONKURE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $507.00K, a 482.76% increase from fiscal 2020.
- ONKURE THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $87.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $26.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $6.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $10.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $10.00K 10-Q · filed 2025-11-06 | |
| 2022-03-31 | $6.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $507.00K 10-K · filed 2022-03-23 | |
| 2021-09-30 | $220.00K 10-Q · filed 2021-11-12 | |
| 2021-03-31 | $139.00K 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $87.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $51.00K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $26.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |